Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marshall Plaut

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Allergy and Clinical Immunology|March 9, 2005
Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidityRebecca S Gruchalla, Jacqueline Pongracic, Marshall Plaut, et al.
The Journal of Allergy and Clinical Immunology|April 21, 2020
Biomarkers of severity and threshold of allergic reactions during oral peanut challengesAlexandra F Santos, George Du Toit, Colin O'Rourke, et al.
The New England Journal of Medicine|March 5, 2016
Effect of Avoidance on Peanut Allergy after Early Peanut ConsumptionGeorge Du Toit, Peter H Sayre, Graham Roberts, et al.
The Journal of Allergy and Clinical Immunology|February 7, 2015
Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trialA Wesley Burks, Robert A Wood, Stacie M Jones, et al.
The New England Journal of Medicine|February 24, 2015
Randomized trial of peanut consumption in infants at risk for peanut allergyGeorge Du Toit, Graham Roberts, Peter H Sayre, et al.
The Journal of Allergy and Clinical Immunology|December 28, 2019
A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocolEdwin H Kim, Stacie M Jones, A Wesley Burks, et al.
Lancet (London, England)|September 17, 2019
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 studyR Sharon Chinthrajah, Natasha Purington, Sandra Andorf, et al.
The Journal of Allergy and Clinical Immunology|December 26, 2012
Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trialDavid M Fleischer, A Wesley Burks, Brian P Vickery, et al.
The Journal of Allergy and Clinical Immunology|March 3, 2019
The MALT1 locus and peanut avoidance in the risk for peanut allergyAlexandra Winters, Henry T Bahnson, Ingo Ruczinski, et al.
The New England Journal of Medicine|July 20, 2012
Oral immunotherapy for treatment of egg allergy in childrenA Wesley Burks, Stacie M Jones, Robert A Wood, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology|March 9, 2005
Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidityRebecca S Gruchalla, Jacqueline Pongracic, Marshall Plaut, et al.
The Journal of Allergy and Clinical Immunology|April 21, 2020
Biomarkers of severity and threshold of allergic reactions during oral peanut challengesAlexandra F Santos, George Du Toit, Colin O'Rourke, et al.
The New England Journal of Medicine|March 5, 2016
Effect of Avoidance on Peanut Allergy after Early Peanut ConsumptionGeorge Du Toit, Peter H Sayre, Graham Roberts, et al.
The Journal of Allergy and Clinical Immunology|February 7, 2015
Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trialA Wesley Burks, Robert A Wood, Stacie M Jones, et al.
The New England Journal of Medicine|February 24, 2015
Randomized trial of peanut consumption in infants at risk for peanut allergyGeorge Du Toit, Graham Roberts, Peter H Sayre, et al.
The Journal of Allergy and Clinical Immunology|December 28, 2019
A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocolEdwin H Kim, Stacie M Jones, A Wesley Burks, et al.
Lancet (London, England)|September 17, 2019
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 studyR Sharon Chinthrajah, Natasha Purington, Sandra Andorf, et al.
The Journal of Allergy and Clinical Immunology|December 26, 2012
Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trialDavid M Fleischer, A Wesley Burks, Brian P Vickery, et al.
The Journal of Allergy and Clinical Immunology|March 3, 2019
The MALT1 locus and peanut avoidance in the risk for peanut allergyAlexandra Winters, Henry T Bahnson, Ingo Ruczinski, et al.
The New England Journal of Medicine|July 20, 2012
Oral immunotherapy for treatment of egg allergy in childrenA Wesley Burks, Stacie M Jones, Robert A Wood, et al.
Pageof 6